| . | Sex (% Female) . | Age (Years, SD) . | Ethnicity (% C/B/Oa) . | Diagnoses (%) . |
|---|---|---|---|---|
| Bloomington (n = 938) | ||||
| CON (n = 333) | 54.3 | 37.3 (11.5) | 30.6/64.0/5.4 | — |
| PSY-C (n = 75) | 36.0 | 43.9 (10.5) | 64.0/32.0/4.0 | Anx (34.7) MDD (6.6) Alc (58.7) |
| HR (n = 88) | 55.7 | 41.2 (12.8) | 43.2/46.6/10.2 | SZRel (63.6) SubSPD (36.4) |
| PSY-P (n = 442) | 44.2 | 40.5 (11.1) | 47.1/47.1/5.8 | SZ (43.9) SZAff (12.2) SPD (16.3) BPD (27.6) |
| Statistics (F or χ 2) | 14.3 | 9.59 | 31.7 | — |
| P-value | .003 | <.001 | <.001 | — |
| Post hocb | — | PSY-C > PSY-P > CON HR > CON | — | — |
| Minneapolis (n = 613) | ||||
| CON (n = 136) | 48.5 | 44.49 (12.6) | 58.0/5.1/37.5 | — |
| HR (n = 176) | 63.4 | 41.33 (12.4) | 53.4/6.2/40.4 | SZRel (55.2) BPRel (44.8) |
| PSY-P (n = 302) | 36.5 | 41.67 (12.3) | 48.8/9.6/39.6 | SZ (46.4) SZAff (18.2) BPD (35.4) |
| Statistics (F or χ 2) | 31.9 | 3.48 | 19.6 | — |
| P-value | <.001 | .03 | .14n.s. | — |
| Post hocb | — | CON > PSY-P CON > HR | — | — |
| . | Sex (% Female) . | Age (Years, SD) . | Ethnicity (% C/B/Oa) . | Diagnoses (%) . |
|---|---|---|---|---|
| Bloomington (n = 938) | ||||
| CON (n = 333) | 54.3 | 37.3 (11.5) | 30.6/64.0/5.4 | — |
| PSY-C (n = 75) | 36.0 | 43.9 (10.5) | 64.0/32.0/4.0 | Anx (34.7) MDD (6.6) Alc (58.7) |
| HR (n = 88) | 55.7 | 41.2 (12.8) | 43.2/46.6/10.2 | SZRel (63.6) SubSPD (36.4) |
| PSY-P (n = 442) | 44.2 | 40.5 (11.1) | 47.1/47.1/5.8 | SZ (43.9) SZAff (12.2) SPD (16.3) BPD (27.6) |
| Statistics (F or χ 2) | 14.3 | 9.59 | 31.7 | — |
| P-value | .003 | <.001 | <.001 | — |
| Post hocb | — | PSY-C > PSY-P > CON HR > CON | — | — |
| Minneapolis (n = 613) | ||||
| CON (n = 136) | 48.5 | 44.49 (12.6) | 58.0/5.1/37.5 | — |
| HR (n = 176) | 63.4 | 41.33 (12.4) | 53.4/6.2/40.4 | SZRel (55.2) BPRel (44.8) |
| PSY-P (n = 302) | 36.5 | 41.67 (12.3) | 48.8/9.6/39.6 | SZ (46.4) SZAff (18.2) BPD (35.4) |
| Statistics (F or χ 2) | 31.9 | 3.48 | 19.6 | — |
| P-value | <.001 | .03 | .14n.s. | — |
| Post hocb | — | CON > PSY-P CON > HR | — | — |
Note: Italic text indicates a significant difference between groups. Alc, alcohol use disorder; Anx, primary anxiety disorder; B, black; BPD, bipolar disorder; BPRel, first-degree relatives of patients with bipolar disorder; C, Caucasian; CON, nonpsychiatric controls; HR, psychosis high risk; MDD, major depressive disorder; n.s., not significant; O, Other; PSY-C, psychiatric controls; PSY-P, psychosis spectrum; SPD, schizotypal personality disorder; Spectrum, schizophrenia spectrum; SZ, schizophrenia; SZAff, schizoaffective disorder; SZRel, first-degree relative of patients with schizophrenia.
aOther indicates mixed race, Asian, Hispanic, and Native Americans (Native Americans are prominent in the Minneapolis sample).
bOnly significant (P < .05) post hoc comparisons are reported.
| . | Sex (% Female) . | Age (Years, SD) . | Ethnicity (% C/B/Oa) . | Diagnoses (%) . |
|---|---|---|---|---|
| Bloomington (n = 938) | ||||
| CON (n = 333) | 54.3 | 37.3 (11.5) | 30.6/64.0/5.4 | — |
| PSY-C (n = 75) | 36.0 | 43.9 (10.5) | 64.0/32.0/4.0 | Anx (34.7) MDD (6.6) Alc (58.7) |
| HR (n = 88) | 55.7 | 41.2 (12.8) | 43.2/46.6/10.2 | SZRel (63.6) SubSPD (36.4) |
| PSY-P (n = 442) | 44.2 | 40.5 (11.1) | 47.1/47.1/5.8 | SZ (43.9) SZAff (12.2) SPD (16.3) BPD (27.6) |
| Statistics (F or χ 2) | 14.3 | 9.59 | 31.7 | — |
| P-value | .003 | <.001 | <.001 | — |
| Post hocb | — | PSY-C > PSY-P > CON HR > CON | — | — |
| Minneapolis (n = 613) | ||||
| CON (n = 136) | 48.5 | 44.49 (12.6) | 58.0/5.1/37.5 | — |
| HR (n = 176) | 63.4 | 41.33 (12.4) | 53.4/6.2/40.4 | SZRel (55.2) BPRel (44.8) |
| PSY-P (n = 302) | 36.5 | 41.67 (12.3) | 48.8/9.6/39.6 | SZ (46.4) SZAff (18.2) BPD (35.4) |
| Statistics (F or χ 2) | 31.9 | 3.48 | 19.6 | — |
| P-value | <.001 | .03 | .14n.s. | — |
| Post hocb | — | CON > PSY-P CON > HR | — | — |
| . | Sex (% Female) . | Age (Years, SD) . | Ethnicity (% C/B/Oa) . | Diagnoses (%) . |
|---|---|---|---|---|
| Bloomington (n = 938) | ||||
| CON (n = 333) | 54.3 | 37.3 (11.5) | 30.6/64.0/5.4 | — |
| PSY-C (n = 75) | 36.0 | 43.9 (10.5) | 64.0/32.0/4.0 | Anx (34.7) MDD (6.6) Alc (58.7) |
| HR (n = 88) | 55.7 | 41.2 (12.8) | 43.2/46.6/10.2 | SZRel (63.6) SubSPD (36.4) |
| PSY-P (n = 442) | 44.2 | 40.5 (11.1) | 47.1/47.1/5.8 | SZ (43.9) SZAff (12.2) SPD (16.3) BPD (27.6) |
| Statistics (F or χ 2) | 14.3 | 9.59 | 31.7 | — |
| P-value | .003 | <.001 | <.001 | — |
| Post hocb | — | PSY-C > PSY-P > CON HR > CON | — | — |
| Minneapolis (n = 613) | ||||
| CON (n = 136) | 48.5 | 44.49 (12.6) | 58.0/5.1/37.5 | — |
| HR (n = 176) | 63.4 | 41.33 (12.4) | 53.4/6.2/40.4 | SZRel (55.2) BPRel (44.8) |
| PSY-P (n = 302) | 36.5 | 41.67 (12.3) | 48.8/9.6/39.6 | SZ (46.4) SZAff (18.2) BPD (35.4) |
| Statistics (F or χ 2) | 31.9 | 3.48 | 19.6 | — |
| P-value | <.001 | .03 | .14n.s. | — |
| Post hocb | — | CON > PSY-P CON > HR | — | — |
Note: Italic text indicates a significant difference between groups. Alc, alcohol use disorder; Anx, primary anxiety disorder; B, black; BPD, bipolar disorder; BPRel, first-degree relatives of patients with bipolar disorder; C, Caucasian; CON, nonpsychiatric controls; HR, psychosis high risk; MDD, major depressive disorder; n.s., not significant; O, Other; PSY-C, psychiatric controls; PSY-P, psychosis spectrum; SPD, schizotypal personality disorder; Spectrum, schizophrenia spectrum; SZ, schizophrenia; SZAff, schizoaffective disorder; SZRel, first-degree relative of patients with schizophrenia.
aOther indicates mixed race, Asian, Hispanic, and Native Americans (Native Americans are prominent in the Minneapolis sample).
bOnly significant (P < .05) post hoc comparisons are reported.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
